GRAYNASDAQHealthcare · Biotechnology

Graybug Vision, Inc.

$5.50-10.80%($-0.67)

TickerSpark Score

47/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRAY research report →

52-Week Range4% of range

Low $4.88

Current $5.50

High $20.30

Companywww.graybug.vision

Graybug Vision, Inc. , a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema.

CEO: Frederic Guerard
IPO: 2020
Employees: 8
HQ: Redwood City, CA, US

Price Chart

-78.62% · this period

Valuation

Market Cap: $120.98M
P/E: -4.22
P/S: 0.00
P/B: -74.78
EV/EBITDA: -4.68
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: 4092.98%
ROIC: -674.61%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-29,562,000 · -115.78%
EPS: $-1.97 · -61.48%
Op Income: $-23,121,000
FCF YoY: -0.25%

Performance & Tape

52W High: $20.30
52W Low: $4.88
50D MA: $8.55
200D MA: $11.51
Beta: 1.20
Avg Volume: 5.28K

Get TickerSpark's AI analysis on GRAY

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Dec 11, 23	WILSON ROBERT N	director	buy	506	$1.67K
Nov 7, 23	Leheny A. Rachel	director, 10 percent owner, officer: Chief Executive Officer	buy	2,000	$6.68K
Nov 6, 23	Roberts Eric W	director, 10 percent owner, officer: Chief Business Officer	buy	2,400	$7.49K
Nov 3, 23	Roberts Eric W	director, 10 percent owner, officer: Chief Business Officer	buy	11,249	$31.85K
Nov 3, 23	Roberts Eric W	director, 10 percent owner, officer: Chief Business Officer	buy	3,700	$10.25K
Nov 6, 23	Leheny A. Rachel	director, 10 percent owner, officer: Chief Executive Officer	buy	2,440	$7.61K
Nov 3, 23	Hebbar Sudarshan	officer: Chief Medical Officer	buy	36,000	$98.60K
Nov 3, 23	Roberts Eric W	director, 10 percent owner, officer: Chief Business Officer	buy	5,860	$15.83K
Nov 3, 23	Roberts Eric W	director, 10 percent owner, officer: Chief Business Officer	buy	3,200	$8.96K
Nov 3, 23	Leheny A. Rachel	director, 10 percent owner, officer: Chief Executive Officer	buy	5,000	$14.25K